Gene Query: FAM83G

Dataset Description Geneva Score
A sister of NANOG regulates genes expressed in pre-implantation human development 124.15
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 58.03
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 55.19
Crizotinib v. DMSO in SW480 cells 49.92
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 40.62
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 37.65
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 33.59
Gene expression in PANC1 cells treated with Rakicidin 33.32
Transcriptome analysis in Neobractatin treated cells 31.49
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 31.37
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 30.43
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 28.5
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 28.21
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 28.21
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 25.51
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 25.19
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 24.79
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 23.14
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 22.31
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  21.65
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 21.02
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 20.89
CD95/Fas ligand mRNA is toxic to cells 19.23
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 18.44
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 18.43
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 18.26
Gene expression analysis of dengue-infected cells 17.72
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 17.49
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 17.35
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 17.32
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 17.19
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 17.08
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 17.01
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 16.94
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 16.82
Tracking of dCas9-methyltransferase footprints 16.53
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 16.3
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 16.27
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 16.27
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 16.25
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 16.21
RNAseq Analysis in glioblastoma cells treated with Mepazine 16.19
RNA-seq analysis to identify the genes regulated by p53-SET interplay 15.98
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 15.71
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 14.67
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 14.65
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 14.61
G-quadruplex structures mark human regulatory chromatin 14.53
TGF-β promotes genomic instability after loss of RUNX3 14.5
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 14.45
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 14.41
Region-specific Innate Antiviral Responses of the Human Epididymis 14.34
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 14.25
Noncoding regions are the main source of targetable tumor-specific antigens 14.11
Selective suppression of endothelial cytokine production by progesterone receptor 14.08
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 14.08
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 14.03
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 13.99
U1 snRNP telescripting regulates size-function stratified human genome 13.98
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 13.85
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 13.71
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 13.66
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 13.62
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 13.45
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 13.45
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 13.1
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 13.1
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 12.86
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 12.84
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 12.62
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 12.62
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 12.56
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 12.54
Transcriptional effect of ETV1 knockdown in melanoma cells 12.54
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 12.53
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 12.52
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 12.46
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 12.38
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 12.26
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 12.25
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 12.24
IL-33 activates tumor stroma to promote intestinal polyposis 12.05
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 12.0
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 12.0
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 11.81
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 11.78
RNA-Sequencing of HepG2 cells treated with TGFBeta 11.68
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 11.67
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 11.67
Identification of the role of polydom in neurofibromas 11.59
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 11.55
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 11.46
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 11.43
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 11.35
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 11.11
Selective expression of long non-coding RNAs in a breast cancer cell progression model 11.04
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 11.03
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 11.03
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 10.94
Ebola virus (EBOV) infection of ARPE-19 cells 10.93
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 10.8
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 10.72
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 10.61
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 10.35
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 10.27
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 10.27
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 10.23
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 10.23
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 10.22
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 10.22
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 10.07
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 10.03
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 9.94
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 9.94
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 9.8
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 9.76
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 9.76
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 9.72
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 9.72
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 9.7
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 9.69
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 9.68
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 9.54
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 9.5
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 9.5
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 9.46
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 9.43
Rorc disruption in human FG pancreatic cancer cells 9.41
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 9.38
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 9.38
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 9.35
Small-molecule targeting of brachyury transcription factor addiction in chordoma 9.32
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 9.31
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 9.31
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 9.16
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 9.1
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 9.06
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 9.0
Transcriptomic and gene ontology profiling of the human corneal cell types 8.99
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 8.95
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 8.91
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 8.86
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 8.81
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 8.79
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 8.76
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 8.69
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 8.68
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 8.67
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 8.62
Effect of drugs on transcriptomic profiles 8.62
A prostate cancer chromatin interaction map 8.59
Chromatin landscape of human visceral and subcutaneous adipocytes 8.52
Primary Human B-cell Temporal Response to CD40L Stimulation 8.49
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 8.46
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 8.43
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 8.39
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 8.36
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 8.34
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 8.34
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 8.19
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 8.18
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 8.18
SUV420H2 knockdown in PANC-1 8.15
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 8.12
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 8.11
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 8.11
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 8.09
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 8.05
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 8.03
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 8.02
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 8.0
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 7.97
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 7.97
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 7.96
Role of CD133 molecule in WNT response and renal repair 7.91
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 7.91
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 7.87
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 7.85
Lysine benzoylation is a novel histone mark 7.81
Lysine benzoylation is a novel histone mark [RNA-seq] 7.81
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 7.75
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 7.72
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 7.7
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 7.7
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 7.7
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 7.67
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 7.66
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 7.65
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 7.65
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 7.62
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 7.62
Genetic-to-epigenetic Therapy for Pancreatic Cancer 7.62
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 7.6
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 7.6
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 7.54
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 7.54
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 7.49
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 7.48
AMPK signaling for naïve pluripotency 7.37
AMPK signaling for naïve pluripotency [Hs] 7.37
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 7.37
RNA-seq of cells with TET1 knockout 7.36
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 7.34
circRNA profile in hypopharyngeal cancer 7.34
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 7.33
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 7.32
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 7.31
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 7.23
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 7.21
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 7.19
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 7.15
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 7.15
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 7.13
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 7.0
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 6.93
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 6.93
Effect of mitochondria deficiency on senescence-associated gene expression 6.92
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 6.92
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 6.91
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 6.9
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 6.9
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 6.89
RNA-sequencing in immortalized human mammary epithelial cells 6.89
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 6.88
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 6.88
Chromatin-informed inference of transcriptional programs in gynecologic cancers 6.88
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 6.83
Effect of disulfiram treatment on pediatric high grade glioma 6.78
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 6.78
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 6.74
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 6.71
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 6.71
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 6.69
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 6.69
Hepatitis C virus functionally sequesters miR-122 6.69
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 6.69
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 6.67
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 6.66
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 6.66
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 6.63
Gene expression changes caused by KRAS in MCF-10A 6.63
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 6.63
Total RNA sequencing of APC mutant and wt colonic organoids 6.61
Role of COP1 on MAP kinase transcriptional output in melanoma 6.61
CSL 6.58
CSL RNA-Seq on HKC and SCC cell lines 6.58
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 6.58
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 6.5
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 6.49
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 6.48
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 6.46
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 6.46
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 6.45
Cajal bodies are linked to genome conformation [RNA-Seq] 6.42
Cajal bodies are linked to genome conformation 6.42
Paxillin regulates genomic networks in prostate cancer [LNCaP] 6.41
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 6.38
Silencing p300 in MCF7 cells to study expression and alternative splicing 6.31
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 6.31
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 6.31
Real-time observation of light-controlled transcription in living cells 6.25
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 6.23
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 6.23
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 6.22
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 6.18
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 6.14
Dynamic reorganization of nuclear architecture during human cardiogenesis 6.14
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 6.14
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 6.12
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 6.12
RNA-sequencing of human tendon after injury 6.11
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 6.1
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 6.08
Human HAP1 cells before and after nutrient deprivation 6.08
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 6.08
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 6.08
High level DNA repair gene expression in human ES cells 6.08
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 6.08
Controlling for gene expression changes in transcription factor protein networks. 6.01
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 6.0
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 5.97
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 5.94
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 5.85
RNA Seq of HMVEC under hypoxia 5.85
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 5.82
Identification of global regulators of T-helper cell lineage specification 5.82
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 5.76
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 5.74
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 5.73
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 5.67
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 5.63
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 5.59
Genome-wide analysis of Dengue virus 2 infected cells 5.58
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 5.57
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 5.56
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 5.53
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 5.52
Effect of ILF3 on translation during homeostasis and the antiviral response 5.44
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 5.43
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 5.42
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 5.39
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 5.39
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 5.36
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 5.36
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 5.36
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 5.33
Functional role of CPPED1 in trophoblasts. 5.32
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 5.3
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 5.26
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 5.04
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 4.99
4sU-seq of HFF exposed to salt and heat stress 4.98
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 4.91
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 4.89
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 4.85
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 4.85
p53 activity results in DNA replication fork processivity 4.79
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 4.78
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 4.77
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 4.71
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 4.71
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 4.69
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 4.52
Regulation of hypoxia-inducible factor activity by ZMYND8 4.5
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 4.48
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 4.44
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 4.39
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 4.31
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 4.28
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 4.28
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 4.28
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 4.28
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 4.28
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 4.28
Illumina Total RNA-seq in HeLa 4.23
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 4.22
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 4.19
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 4.17
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 4.13
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 4.11
HEK293 Heat-shock experiment 4.07
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 4.07
RNA-seq of naive and primed ES cells (NHSM) 4.06
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 4.01
Epigenome regulation during epidermal lineage commitment 4.0
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 3.97
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 3.95
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 3.95
RNA sequencing of mechanically strained NHEKs and control NHEKs 3.92
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 3.85
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 3.85
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 3.69
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 3.69
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 3.67
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 3.6
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 3.58
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 3.56
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 3.53
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 3.49
CHD1 regulates cell fate determination by activation of differentiation-induced genes 3.45
Generation of trichogenic adipose-derived stem cells by expression of three factors 3.42
Determining mRNA half-lives on a transcriptome-wide scale 3.4
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 3.29
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 3.29
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 3.26
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 3.26
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 3.24
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 3.24
The cytokine environment influence on human skin-derived T cells 3.22
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 3.17
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 3.11
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 3.1
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 3.1
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 3.09
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 3.09
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 3.08
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 3.05
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 3.05
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 3.03
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 3.03
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 2.98
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 2.94
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 2.91
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 2.9
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 2.86
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 2.83
ARID1A and ARID1B loss in HCT116 and TOV21G cells 2.81
Gene expression analysis upon mtDNA depletion 2.75
Gene expression analysis upon mtDNA depletion [RNA-seq] 2.75
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 2.73
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 2.72
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 2.7
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 2.65
RNA-seq analysis upon ARID1B overexpression 2.58
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 2.56
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 2.49
NKX2.2 2.45
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 2.45
Transcriptome analysis of human lung epithelial cells 2.45
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 2.42
Expression profiling of converted and control dermal BJ fibroblasts 2.38
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 2.38
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 2.36
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 2.36
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 2.31
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 2.31
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 2.29
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 2.27
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 2.25
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 2.25
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 2.21
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 2.2
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 2.18
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.14
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 2.09
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 2.08
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 2.04
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 2.04
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 1.89
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 1.89
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 1.89
An siRNA screen identifies CHD4 as a target for epigenetic therapy 1.87
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 1.86
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 1.84
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 1.8
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 1.68
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 1.65
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 1.65
Effect of BB608 on Gene Expression in HNSCC Cell Line 1.62
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 1.61
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 1.54
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 1.51
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 1.51
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 1.38
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 1.38
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 1.38
Functional Haploid Human Oocytes Generated from Polar Body Genomes 1.32
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 1.32
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 1.3
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 1.29
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 1.29
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 1.29
Gene profiling of human adult and pediatric liver cancer cells 1.25
UV_24h_GRO-Seq 1.25
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 1.25
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 1.22
p63 controls the enhancer landscape during keratinocyte differentiation 1.22
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 1.21
RNA-seq of MDA-MB-231 cells with TET1 knockout 1.1
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 1.09
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 1.07
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 1.01
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 0.94
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 0.86
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 0.86
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.86
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.86
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 0.85
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 0.85
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.83
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 0.79
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.75
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.75
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 0.73
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.7
H1609088 Human RNA-Sequencing 0.68
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 0.67
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 0.67
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 0.62
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 0.57
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.56
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.56
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.54
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.43
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 0.43
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 0.4
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.39
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 0.38
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 0.38
The role of m6A/m-RNA methylation in stress response regulation 0.32
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.32
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 0.32
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 0.3
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 0.3
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 0.3
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 0.29
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 0.27
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 0.27
Gene expression profile of CRC-derived HILEC 0.25
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.23
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.19
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 0.16
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.14
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 0.09
RNA Seq of Alagille liver biopsies 0.08
Alagille_Nodder 0.08
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.05
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.05
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 0.03
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation